Efficacy of Leizumab Vitreous Combined Treatment of Neovascular Glau-coma Caused by Fundus Retinal Vein Obstruction
Objective To explore the therapeutic significance of leizumab vitreous in the treatment of neovascular glaucoma caused by fundus retinal vein obstruction.Methods A total of 80 patients with neovascular glaucoma who came to Changzhou Seventh People's Hospital from June 2019 to December 2022 were randomly selected and they were divided into two groups according to random number table method.40 patients in the control group received com-bined trabeculectomy,and 40 patients in the observation group received leizumab vitreous therapy plus combined trab-eculectomy.The treatment results,intraocular pressure(IOP),visual acuity and the incidence of adverse reactions were compared.Results The effective rate of observation group was 97.50%,which was higher than that of control group(82.50%),and the difference was statistically significant(χ2=5.000,P<0.05).Before treatment,there was no sta-tistically significant difference in IOP and visual acuity between two groups(both P>0.05).After treatment,the index of observation group were better than those of the control group,and the differences were statistically significant(both P<0.05).The incidence of adverse reactions was lower in the observation group than that in the control group,and the difference was statistically significant(P<0.05).Conclusion Leizumab vitreous combined trabeculectomy has a more accurate effect,and the intraocular pressure and visual acuity of the patients with neovascular glaucoma caused by fundus retinal vein occlusion are improved after treatment,and the incidence of adverse reactions are lower.
NETL
NSTL
万方数据
维普
